Highlights and Quick Summary
- Operating Cash Flow Growth for the quarter ending September 30, 2022 was -25.77 (a 4144.76% increase compared to previous quarter)
- Year-over-year quarterly Operating Cash Flow Growth decreased by -2496.93%
- Annual Operating Cash Flow Growth for 2021 was 0.31 (a -193.36% decrease from previous year)
- Annual Operating Cash Flow Growth for 2020 was -0.33 (a -87.06% decrease from previous year)
- Annual Operating Cash Flow Growth for 2019 was -2.55 (a -60.8% decrease from previous year)
Visit stockrow.com/BEAM
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Operating Cash Flow Growth of Beam Therapeutics Inc.
Most recent Operating Cash Flow Growthof BEAM including historical data for past 10 years.Interactive Chart of Operating Cash Flow Growth of Beam Therapeutics Inc.
Beam Therapeutics Inc. Operating Cash Flow Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | -25.77 | -0.61 | 6.66 | – |
| 2021 | 1.08 | 1.14 | -0.42 | -0.41 | 0.31 |
| 2020 | -0.37 | -0.25 | -1.01 | -0.06 | -0.33 |
| 2019 | 0.12 | 0.2 | 0.5 | 0.06 | -2.55 |
| 2018 | – | – | – | -0.14 | -6.5 |
| 2017 | – | – | – | – | 0.87 |
Business Profile of Beam Therapeutics Inc.
Sector: Healthcare
Industry: Biotechnology